4//SEC Filing
Stehman-Breen Catherine 4
Accession 0001209191-23-032280
CIK 0001818794other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 6:38 PM ET
Size
5.3 KB
Accession
0001209191-23-032280
Insider Transaction Report
Form 4
Stehman-Breen Catherine
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-24+24,900→ 24,900 totalExercise: $13.49Exp: 2033-05-23→ Common Stock (24,900 underlying)
Footnotes (1)
- [F1]This option was granted on May 24, 2023. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 24, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001702233
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 6:38 PM ET
- Size
- 5.3 KB